A1C target ranges for the study sample (N = 402,403)
| . | Diabetes complications . | ||
|---|---|---|---|
| Life expectancya . | Absent or mild (DCSI = 0–1) . | Moderate (DCSI = 2–3) . | Advanced (DCSI ≥4) . |
| >10 years | |||
| A1C range, % (mmol/mol) | 6.0–7.0 (42–53) | 7.0–8.0 (53–64) | 7.5–8.5 (58–69) |
| n (%) | 56,124 (14.0) | 73,968 (18.4) | 82,764 (20.6) |
| 5–10 years | |||
| A1C range, % (mmol/mol) | 7.0–8.0 (53–64) | 7.5–8.5 (58–69) | 7.5–8.5 (58–69) |
| n (%) | 13,069 (3.3) | 31,293 (7.8) | 76,873 (19.1) |
| <5 years | |||
| A1C range, % (mmol/mol) | 8.0–9.0 (64–75) | 8.0–9.0 (64–75) | 8.0–9.0 (64–75) |
| n (%) | 3,926 (1.0) | 12,278 (3.1) | 51,748 (12.9) |
| . | Diabetes complications . | ||
|---|---|---|---|
| Life expectancya . | Absent or mild (DCSI = 0–1) . | Moderate (DCSI = 2–3) . | Advanced (DCSI ≥4) . |
| >10 years | |||
| A1C range, % (mmol/mol) | 6.0–7.0 (42–53) | 7.0–8.0 (53–64) | 7.5–8.5 (58–69) |
| n (%) | 56,124 (14.0) | 73,968 (18.4) | 82,764 (20.6) |
| 5–10 years | |||
| A1C range, % (mmol/mol) | 7.0–8.0 (53–64) | 7.5–8.5 (58–69) | 7.5–8.5 (58–69) |
| n (%) | 13,069 (3.3) | 31,293 (7.8) | 76,873 (19.1) |
| <5 years | |||
| A1C range, % (mmol/mol) | 8.0–9.0 (64–75) | 8.0–9.0 (64–75) | 8.0–9.0 (64–75) |
| n (%) | 3,926 (1.0) | 12,278 (3.1) | 51,748 (12.9) |
Life expectancy was based on predicting the likelihood of mortality in <5 years, 5–10 years, and ≥10 years in the 3rd year of baseline.